Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001019695-15-000049)

Filing Details

Accession Number:: 0001019695-15-000049
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-12-11 12:47:40
Reporting Period:: 2015-12-09

Filing Date:: 2015-12-11
Accepted Time:: 2015-12-11 12:47:40
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1019695	Arqule Inc	ARQL	Pharmaceutical Preparations (2834)	043221586

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1436861	Paolo Pucci	C/O Arqule, Inc. 1 Wall Street, 6Th Floor Burlington MA 01803	Chief Executive Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2015-12-09	1,009	$2.10	248,289	No	4	P	Direct
Common Stock	Acquisiton	2015-12-10	6,600	$2.10	254,889	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct
No	4	P	Direct

Footnotes

Reflects the weighted average price as the shares were purchased in multiple transactions. The per share transaction price ranged from $2.085 to $2.10. The Reporting Person hereby undertakes to provide, upon request, by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.